2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 37,862 | 100,387 | 91,496 | 54,522 | 248,122 |
| Cost of Goods | 18,010 | 16,918 | 16,577 | 11,837 | 5,396 |
| Gross Profit | 19,852 | 83,469 | 74,919 | 42,685 | 242,726 |
| Operating Expenses | 135,292 | 321,995 | 338,636 | 357,470 | 381,292 |
| Operating Income | -115,430 | -237,608 | -263,140 | -313,948 | -138,170 |
| Other Income | 58,183 | 20,038 | 8,987 | 21,735 | 18,056 |
| Pre-tax Income | -57,247 | -217,570 | -254,153 | -292,213 | -120,114 |
| Net Income Continuous | -57,247 | -217,570 | -254,153 | -292,213 | -120,114 |
| Net Income | $-57,247 | $-217,570 | $-254,153 | $-292,213 | $-120,114 |
| EPS Basic Total Ops | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 |
| EPS Basic Continuous Ops | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 |
| EPS Diluted Total Ops | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 |
| EPS Diluted Continuous Ops | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 |
| EPS Diluted Before Non-Recurring Items | -1.60 | -4.00 | -7.13 | -12.44 | N/A |
| EBITDA(a) | $-108,334 | $-215,267 | $-251,607 | $-297,598 | $-124,982 |